| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |